Total Payments
$321,210
2022 Payments
$1,003
Companies
8
Transactions
228
Payment Breakdown by Category
Travel$127,605 (39.7%)
Consulting$106,685 (33.2%)
Other$83,660 (26.0%)
Food & Beverage$3,260 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $127,605 | 129 | 39.7% |
| Consulting Fee | $106,685 | 24 | 33.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $83,660 | 13 | 26.0% |
| Food and Beverage | $3,260 | 62 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $231,102 | 141 | $0 (2022) |
| Shionogi Inc | $82,266 | 76 | $0 (2020) |
| Philips Electronics North America Corporation | $7,676 | 3 | $0 (2018) |
| Aurinia Pharma U.S., Inc. | $66.39 | 3 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $47.66 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $19.56 | 1 | $0 (2017) |
| Paratek Pharmaceuticals, Inc. | $18.45 | 1 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $13.81 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,003 | 4 | Merck Sharp & Dohme LLC ($930.00) |
| 2021 | $1,166 | 3 | Merck Sharp & Dohme Corporation ($1,125) |
| 2020 | $40,309 | 23 | Shionogi Inc ($35,274) |
| 2019 | $67,750 | 78 | Merck Sharp & Dohme Corporation ($34,175) |
| 2018 | $68,201 | 32 | Merck Sharp & Dohme Corporation ($55,001) |
| 2017 | $142,780 | 88 | Merck Sharp & Dohme Corporation ($134,854) |
All Payment Transactions
228 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| 03/11/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/25/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Cardio-renal | ||||||
| 09/17/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Cardio-renal | ||||||
| 07/27/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/01/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| 12/16/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| 11/17/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: ANTIBIOTIC | ||||||
| 09/11/2020 | Merck Sharp & Dohme Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| 07/09/2020 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $2,730.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/02/2020 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $1,170.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/01/2020 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $390.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/12/2020 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $4,250.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/12/2020 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $1,560.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/12/2020 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $24.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/05/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $122.80 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/05/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/12/2020 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $73.60 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/12/2020 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $13.14 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/11/2020 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $610.41 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/11/2020 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $229.08 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/11/2020 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $128.22 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/11/2020 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $84.60 | General |
| Category: Infections and Infectious Diseases | ||||||
| 01/16/2020 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $12,000.00 | General |
| Category: Infections and Infectious Diseases | ||||||
About Dr. George Karam, MD
Dr. George Karam, MD is a Cardiovascular Disease healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548282312.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Karam, MD has received a total of $321,210 in payments from pharmaceutical and medical device companies, with $1,003 received in 2022. These payments were reported across 228 transactions from 8 companies. The most common payment nature is "Travel and Lodging" ($127,605).
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Baton Rouge, LA
- Active Since 07/24/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1548282312
Products in Payments
- Fetroja (Drug) $68,849
- ZERBAXA (Drug) $8,316
- INVANZ (Drug) $7,195
- PCMS Und (Device) $4,716
- CardioMD (Device) $2,960
- LUPKYNIS (Drug) $66.39
- Kerendia (Drug) $47.66
- JANUVIA (Drug) $20.95
- Cresemba (Drug) $19.56
- NUZYRA (Drug) $18.45
- TOUJEO (Drug) $13.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Baton Rouge
Denzil Moraes, M.d, M.D
Cardiovascular Disease — Payments: $1.3M
Cardiovascular Disease $1.3M
David Moll, Md, MD
Cardiovascular Disease — Payments: $128,748
Cardiovascular Disease $128,748
Mark Pollet, Md, MD
Cardiovascular Disease — Payments: $116,274
Cardiovascular Disease $116,274
Dr. Tara Jarreau, M.d, M.D
Cardiovascular Disease — Payments: $111,344
Cardiovascular Disease $111,344
Venkata Satish Gadi, M.d, M.D
Cardiovascular Disease — Payments: $105,858
Cardiovascular Disease $105,858
Steven Kelley, Md, MD
Cardiovascular Disease — Payments: $82,130
Cardiovascular Disease $82,130